NanoTafla Nanocomposite as a Novel Low-Cost and Eco-Friendly Sorbent for Strontium and Europium Ions

por Abu Elgoud, Elsayed M., Aly, Mohamed I., Hamed, Mostafa M., Nayl, AbdElAziz A.
Publicado 2022

Structure-Guided Optimization of Small-Molecule Folate Uptake Inhibitors Targeting the Energy-Coupling Factor Transporters

por Kiefer, Alexander F., Bousis, Spyridon, Hamed, Mostafa M., Diamanti, Eleonora, Haupenthal, Jörg, Hirsch, Anna K.H.
Publicado 2022

Targeting the IspD Enzyme in the MEP Pathway: Identification of a Novel Fragment Class

por Diamanti, Eleonora, Hamed, Mostafa M., Lacour, Antoine, Bravo, Patricia, Illarionov, Boris, Fischer, Markus, Rottmann, Matthias, Witschel, Matthias, Hirsch, Anna K. H.
Publicado 2022

Design and Synthesis of Novel Bis-Imidazolyl Phenyl Butadiyne Derivatives as HCV NS5A Inhibitors

por Hamdy, Jehad, Emadeldin, Nouran, Hamed, Mostafa M., Frakolaki, Efseveia, Katsamakas, Sotirios, Vassilaki, Niki, Zoidis, Grigoris, Hirsch, Anna K. H., Abdel-Halim, Mohammad, Abadi, Ashraf H.
Publicado 2022

Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors

por Darwish, Sarah S., Chen, Po-Jen, Hamed, Mostafa M., Wagdy, Reem A., Chen, Shun-Hua, Abadi, Ashraf H., Abdel-Halim, Mohammad, Hwang, Tsong-Long, Engel, Matthias
Publicado 2022

Cystobactamid 507: Concise Synthesis, Mode of Action, and Optimization toward More Potent Antibiotics

por Elgaher, Walid A. M., Hamed, Mostafa M., Baumann, Sascha, Herrmann, Jennifer, Siebenbürger, Lorenz, Krull, Jana, Cirnski, Katarina, Kirschning, Andreas, Brönstrup, Mark, Müller, Rolf, Hartmann, Rolf W.
Publicado 2020

Expanding the Myxochelin Natural Product Family by Nicotinic Acid Containing Congeners

por Frank, Nicolas A., Széles, Márió, Akone, Sergi H., Rasheed, Sari, Hüttel, Stephan, Frewert, Simon, Hamed, Mostafa M., Herrmann, Jennifer, Schuler, Sören M. M., Hirsch, Anna K. H., Müller, Rolf
Publicado 2021

Synthetic studies of cystobactamids as antibiotics and bacterial imaging carriers lead to compounds with high in vivo efficacy

por Testolin, Giambattista, Cirnski, Katarina, Rox, Katharina, Prochnow, Hans, Fetz, Verena, Grandclaudon, Charlotte, Mollner, Tim, Baiyoumy, Alain, Ritter, Antje, Leitner, Christian, Krull, Jana, van den Heuvel, Joop, Vassort, Aurelie, Sordello, Sylvie, Hamed, Mostafa M., Elgaher, Walid A. M., Herrmann, Jennifer, Hartmann, Rolf W., Müller, Rolf, Brönstrup, Mark
Publicado 2019

Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle (Adv. Sci. 5/2023)

por Hamed, Mostafa M., Abdelsamie, Ahmed S., Rox, Katharina, Schütz, Christian, Kany, Andreas M., Röhrig, Teresa, Schmelz, Stefan, Blankenfeldt, Wulf, Arce‐Rodriguez, Alejandro, Borrero‐de Acuña, José Manuel, Jahn, Dieter, Rademacher, Jessica, Ringshausen, Felix C., Cramer, Nina, Tümmler, Burkhard, Hirsch, Anna K. H., Hartmann, Rolf W., Empting, Martin
Publicado 2023

Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle

por Hamed, Mostafa M., Abdelsamie, Ahmed S., Rox, Katharina, Schütz, Christian, Kany, Andreas M., Röhrig, Teresa, Schmelz, Stefan, Blankenfeldt, Wulf, Arce‐Rodriguez, Alejandro, Borrero‐de Acuña, José Manuel, Jahn, Dieter, Rademacher, Jessica, Ringshausen, Felix C., Cramer, Nina, Tümmler, Burkhard, Hirsch, Anna K. H., Hartmann, Rolf W., Empting, Martin
Publicado 2023